Personalized circulating tumor DNA analysis as predictor of efficacy of neoadjuvant therapy in HER2-positive breast cancer: A prospective study (NCT06479460).

Authors: Jing Wu, Huan Yin, Junzhe Yang, Ying Ding, Rongrong Chen, Jue Wang, Xiaoming Zha, Xiaoan Liu, Zhihong Zhang

Published: 2025-05-28

DOI: 10.1200/jco.2025.43.16_suppl.e12604

Source: Full article

---

Abstract

e12604